Study of Association Between Different Coronary Artery Disease Presentations and Its Effect on Short-Term Mortality,

Mansoor Ahmad1, Muhammad Asghar2, Udit Joshi1

  • 1Cardiology, University of Illinois College of Medicine at Peoria, Peoria, USA.

Cureus
|September 13, 2021
PubMed

Insights

Percutaneous coronary intervention (PCI) for coronary artery disease (CAD) is associated with lower 30-day readmission and mortality rates. However, PCI increases the overall cost of admission across all CAD presentation types.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Economics

Background:

  • Atherosclerotic coronary artery disease (CAD) is a leading cause of mortality in the USA.
  • CAD presentation varies widely, impacting treatment strategies and outcomes.
  • Understanding the cost-effectiveness of interventions like percutaneous coronary intervention (PCI) is crucial for healthcare management.

Purpose of the Study:

  • To review the cost of admission and PCI stratified by different CAD presentation types.
  • To evaluate the impact of PCI on 30-day readmission and mortality rates in patients with CAD.

Main Methods:

  • Retrospective study of 6,403 patients undergoing coronary angiography from 2015-2017, selected from the CathPCI registry.
  • Patients were stratified by CAD presentation (asymptomatic to STEMI) and need for PCI.
  • Analysis included chart review for readmission/death data, cost data, and adjusted linear regression for outcomes.

Main Results:

  • 2,444 patients (38%) required PCI, with a lower mean age and BMI compared to the non-PCI group.
  • The PCI group demonstrated significantly lower odds of 30-day readmission (OR: 0.63) and 30-day mortality (OR: 0.60).
  • While PCI improved clinical outcomes, it increased the cost of admission across all CAD presentation types.

Conclusions:

  • Percutaneous coronary intervention (PCI) is associated with improved 30-day clinical outcomes (reduced readmission and mortality) in patients with coronary artery disease (CAD).
  • Despite better patient outcomes, PCI leads to increased admission costs irrespective of the CAD presentation severity.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
80
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
54
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
134